PETMED EXPRESS INC
PETMED EXPRESS INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | 4 | 4 | |||||
Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Inventory Finished Goods | - | - | - | - | - | - | - | 26 | 29 | 35 | 19 | 32 | |||||
Cash And Cash Equivalents At Carrying Value | 21 | 27 | 36 | 41 | 55 | 50 | 52 | 46 | 55 | 49 | 53 | 62 | |||||
Accounts Receivable Net Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | |||||
Inventory Net | 14 | 12 | 15 | 18 | 16 | 12 | 13 | - | 29 | - | - | - | |||||
Prepaid Expense And Other Assets Current | 6 | 8 | 6 | 7 | 5 | 4 | 4 | 4 | 6 | 9 | 10 | 9 | |||||
Prepaid Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | |||||
Assets Current | 44 | 49 | 59 | 68 | 79 | 68 | 71 | 78 | 94 | 96 | 85 | 105 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 26 | 28 | 28 | 29 | 29 | 28 | 26 | 26 | 27 | 27 | 27 | 27 | |||||
Goodwill | 0 | 0 | 0 | 0 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Assets Noncurrent | 38 | 39 | 41 | 42 | 70 | 76 | 75 | 75 | 76 | 78 | 78 | 79 | |||||
Deferred Income Tax Assets Net | - | - | - | - | 0 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | |||||
Assets | 81 | 88 | 100 | 110 | 149 | 145 | 146 | 153 | 170 | 173 | 163 | 184 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 21 | 20 | 19 | 20 | 24 | 11 | 17 | 24 | 37 | 39 | 25 | 40 | |||||
Sales And Excise Tax Payable Current | 22 | 25 | 25 | 25 | 25 | 24 | 24 | 25 | 25 | 24 | 25 | 27 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Contract With Customer Liability Current | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 3 | 4 | 3 | |||||
Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | - | - | 1 | 0 | - | - | - | |||||
Liabilities Current | 52 | 55 | 57 | 58 | 63 | 48 | 49 | 58 | 72 | 72 | 61 | 79 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 52 | 55 | 57 | 58 | 64 | 49 | 50 | 59 | 73 | 73 | 62 | 80 | |||||
Commitments And Contingencies | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Preferred Stock Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 20 | 19 | 19 | 19 | 19 | 18 | 18 | 17 | 25 | 23 | 22 | 20 | |||||
Retained Earnings Accumulated Deficit | 9 | 13 | 24 | 32 | 67 | 78 | 79 | 77 | 72 | 77 | 79 | 84 | |||||
Stockholders Equity | 29 | 33 | 43 | 52 | 85 | 96 | 96 | 94 | 97 | 100 | 100 | 104 | |||||
Liabilities And Stockholders Equity | 81 | 88 | 100 | 110 | 149 | 145 | 146 | 153 | 170 | 173 | 163 | 184 | |||||
Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Liquidation Preference | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | |||||
Common Stock Shares Issued | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | |||||
Shares Outstanding | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | -7.78% | -20.00% | -27.50% | -8.05% | -25.17% | -23.15% | -17.37% | -6.57% | - |
| 2025 | 0.95% | 16.46% | 22.47% | -19.20% | -9.95% | -13.79% | -20.49% | -33.40% | -31.31% | 0.78% | -35.55% | 28.91% |
| 2024 | -14.08% | -16.37% | -24.22% | 8.85% | 9.14% | -2.18% | -0.73% | 5.60% | -5.84% | -6.30% | -11.14% | -22.76% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.84 | 0.89 | 1.05 | 1.18 | 1.26 | 1.43 | 1.45 | 1.33 | 1.30 | 1.32 | 1.38 | 1.33 | |||||
| Quick Ratio | 0.45 | 0.52 | 0.68 | 0.75 | 0.91 | 1.10 | 1.11 | 0.83 | 0.81 | 0.72 | 0.92 | 0.81 | |||||
| Working Capital | -8.47M | -6.26M | 2.77M | 10.28M | 16.10M | 20.42M | 21.95M | 19.32M | 21.49M | 23.15M | 23.40M | 26.05M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.81 | 1.68 | 1.33 | 1.13 | 0.75 | 0.51 | 0.51 | 0.63 | 0.76 | 0.73 | 0.62 | 0.77 | |||||
| Interest Coverage TTM | -29.32 | -67.97 | -72.57 | -75.00 | -3.55 | 1.94 | -4.41 | -4.00 | -15.97 | -9.44 | -6.48 | 3.15 | |||||
| Debt Ratio | 0.64 | 0.63 | 0.57 | 0.53 | 0.43 | 0.34 | 0.34 | 0.39 | 0.43 | 0.42 | 0.38 | 0.43 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.56 | 1.61 | 1.61 | 1.61 | 1.42 | 1.53 | 1.66 | 1.60 | 1.67 | 1.62 | 1.63 | 1.52 | |||||
| Days Sales Outstanding TTM | 4.31 | 3.73 | 3.30 | 3.33 | 4.50 | 3.15 | 2.70 | 2.82 | 3.26 | 2.55 | 2.54 | 2.53 | |||||
| Receivables Turnover TTM | 84.74 | 97.94 | 110.61 | 109.65 | 81.06 | 115.88 | 134.99 | 129.50 | 111.91 | 142.99 | 143.74 | 144.06 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -2.74 | -3.09 | -2.63 | -2.13 | -0.30 | 0.02 | -0.05 | -0.12 | -0.37 | -0.13 | -0.04 | 0.06 | |||||
| Free Cash Flow Per Share TTM | -1.58 | -1.09 | -0.75 | -0.23 | -0.02 | 0.04 | -0.04 | -0.43 | -0.01 | 0.08 | 0.85 | 0.81 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.31 | 0.61 | 0.91 | 1.21 | 1.21 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 28.05% | 27.53% | 29.33% | 30.43% | 30.46% | 32.23% | 31.24% | 30.21% | 30.16% | 28.11% | 27.80% | 27.74% | |||||
| Operating Profit Margin TTM | -32.77% | -31.56% | -24.71% | -18.90% | -0.67% | 0.27% | -0.77% | -0.61% | -2.90% | -1.64% | -0.83% | 0.23% | |||||
| Net Profit Margin TTM | -32.00% | -34.70% | -27.75% | -20.84% | -2.76% | 0.15% | -0.38% | -0.96% | -2.66% | -0.96% | -0.31% | 0.50% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -21.13% | -22.97% | -22.57% | -21.22% | -19.25% | -12.37% | -5.34% | 1.60% | 9.54% | 6.92% | 3.69% | 0.67% | |||||
| Net Income Growth (1Y) | 813.51% | -18,270.59% | 5,613.71% | 1,616.28% | -15.98% | -113.40% | 13.43% | -295.44% | -245.21% | -129.48% | -106.29% | -92.24% | |||||
| EPS Growth (1Y) | 799.30% | -17,947.22% | 5,534.02% | 1,596.26% | -16.80% | -113.26% | 12.24% | -293.73% | -244.35% | -129.30% | -106.25% | -92.29% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.83 | -1.04 | -0.95 | -1.56 | -13.76 | 278.60 | -78.71 | -32.28 | -13.09 | -57.96 | -246.08 | 207.95 | |||||
| P/B TTM | 1.65 | 2.05 | 1.22 | 1.34 | 1.01 | 1.03 | 0.79 | 0.89 | 1.01 | 1.54 | 2.08 | 2.63 | |||||
| P/S TTM | 0.27 | 0.36 | 0.26 | 0.33 | 0.38 | 0.41 | 0.30 | 0.31 | 0.35 | 0.56 | 0.77 | 1.03 | |||||
| Market Cap | 47.70M | 67.23M | 52.43M | 68.91M | 86.30M | 99.46M | 75.80M | 83.08M | 97.70M | 154.42M | 208.93M | 273.87M | |||||
| Enterprise Value | 26.29M | 40.31M | 16.33M | 27.78M | 31.58M | 49.36M | 23.75M | 37.09M | 42.40M | 104.98M | 155.45M | 212.33M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -33.05M | -22.96M | -15.68M | -4.76M | -395.00K | 855.00K | -918.00K | -8.80M | -194.00K | 1.73M | 17.42M | 16.55M | |||||
| Net Debt | -21.41M | -26.91M | -36.10M | -41.13M | -54.72M | -50.10M | -52.05M | -45.99M | -55.30M | -49.44M | -53.47M | -61.53M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
PETMED EXPRESS INC (PETS) — SEC Financial Statements & Analysis
PETMED EXPRESS INC (PETS) is a retail-drug stores and proprietary stores company, incorporated in FL. PETMED EXPRESS INC trades on PETS: Nasdaq as: PETS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), PETMED EXPRESS INC reported a -21.13% year-over-year revenue growth, a Gross Profit Margin of 28.05% (TTM), a Debt-to-Equity ratio of 1.81x, a Price-to-Sales (P/S) ratio of 0.27x (TTM), a Price-to-Book (P/B) ratio of 1.65 (TTM), at a market cap of $47.70M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -21.13%
- Gross Profit Margin TTM
- 28.05%
- Debt To Equity
- 1.81x
- P/S TTM
- 0.27x
- P/B TTM
- 1.65
- Market Cap
- $47.70M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PETMED EXPRESS INC in?
PETMED EXPRESS INC (PETS) operates in the Retail-Drug Stores and Proprietary Stores industry.
What is PETS's market cap?
PETMED EXPRESS INC (PETS) has a market capitalization of $47.70M as of 2026-03-31.
What exchange does PETS trade on?
PETMED EXPRESS INC (PETS) trades on the PETS: Nasdaq.
Where is PETMED EXPRESS INC incorporated?
PETMED EXPRESS INC is incorporated in FL.